secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2022-10-14T23:59:59+00:00
Accession:  0001564590-22-034280
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo shareholders approve 2022 equity plan; Cohen and Gobel elected directors
--------------------------------------------------------------------------------

- Stockholders approved 2022 Equity Incentive Plan with 94.35% of votes cast; 1,236,738 shares reserved.
- Douglas Jay Cohen and David Gobel elected as Class II directors with votes for 1,845,765 and 1,879,778 respectively.
- Mayer Hoffman McCann P.C. ratified as auditor for fiscal 2023 with 98.36% of votes cast.
- Advisory vote on executive compensation approved with 92.40% of votes cast.
- 2021 Inducement Plan share reserve reduced from 750,000 to 51,000 shares effective October 12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000156459022034280/0001564590-22-034280-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000156459022034280/onvo-8k_20221012.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-034280

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer